Honouring World Haemophilia Day
Today, we commemorate World Hemophilia Day, a momentous occasion to raise awareness about hemophilia and other bleeding disorders that affect millions worldwide.
The theme of the event this year is “Equitable access for all: recognizing all bleeding disorders”. The World Federation of Hemophilia (WFH) vision of ‘Treatment for All’ is for a world where all people with inherited bleeding disorders have access to care, regardless of their type of bleeding disorder, gender, age, or where they live.
Our portfolio company PROFACTOR PHARMA LTD‘s mission is to transform treatment availability for haemophilia A patients by providing an affordable recombinant FVIII treatment to those who cannot access or afford the treatment.
The ProFactor Pharma team will be attending the WFH Congress in Madrid, from April 21-24 and will also be present at BioTrinity April 23-24 in London with a pitch presentation by CEO Jaymin Amin on Wed April 24.
